Featured articles from the journal CHEST®, August 2023

Published monthly, the journal CHEST^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The August issue of the CHEST journal contains 47 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resources, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“With recommendations for mouthpiece ventilation, transition to home mechanical ventilation, salivary secretion management and airway clearance therapies, the August issue contains new clinical practice guideline, ‘Respiratory Management of Patients With Neuromuscular Weakness,’” says Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “Also featured in the August issue is the multisociety evidence review, ‘Effect of Race and Ethnicity on Pulmonary Function Testing Interpretation.’”

Additional highlights from the latest issue of the journal CHEST include:

• Diffuse Lung Disease Original research, “Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosis,” shows that, among 14,792 veterans with idiopathic pulmonary fibrosis, 17% received antifibrotics, and there were significant disparities in adoption associated with sex, race, and residence. View the visual abstract for this research.

• Pulmonary Vascular In a retrospective observational study, “Prognostic Value of Respiratory Variation in Right Atrial Pressure in Patients With Precapillary Pulmonary Hypertension,” lack of respiratory variation in right atrial pressure was associated with lower cardiac index. View the visual abstract for this research.

• Sleep A large cohort study, “Polysomnographic Assessment of Sleep Disturbances in Cancer Development,” confirms the importance of polysomnographic phenotypes and highlights the role that periodic limb movements of sleep and oxygenation desaturation may play in cancer. View the visual abstract for this research

---

Notes for editors

To view the entire August issue of CHEST journal (volume 164, issue 2), published by Elsevier, visit journal.chestnet.org and follow @journal_CHEST on social media for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, Senior Specialist, Communications and Public Relations, American College of Chest Physicians (CHEST), at [email protected].

About the journal CHEST^®  

 The journal CHEST, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.org.

About the American College of Chest Physicians 

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.

About Elsevier

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies to help impact makers achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @ElsevierConnect.